HIV testing and pre-exposure prophylaxis (PrEP) are recommended in Germany for individuals at increased HIV risk. However, data on HIV testing, PrEP use, and PrEP knowledge among trans and non-binary people are limited. We analysed data from the 'Sexuelle Gesundheit in trans und nicht-binären Communitys' (TASG) study, a participatory study on HIV/STI and sexual health among trans and non-binary people in Germany. The study was designed, promoted, and analysed with active involvement of community members. Participants were invited to complete an anonymous online survey between 1 March and 1 July 2022. The outcomes included HIV testing within the last 5 years, PrEP use, and PrEP-specific knowledge. Predictors for HIV testing were identified using a bootstrap stepwise selection procedure. Among 2468 HIV-negative participants with information on potential HIV risks, 21.5% had potential needs for HIV testing and PrEP. Of these, only 44.3% (208/470, missing: 60) reported testing for HIV within the last 5 years. Older participants, those living in larger cities, and those with higher education levels were more likely to have tested for HIV. Additionally, only 8.3% (38/459, missing: 71) reported ever using PrEP. Among 451 participants with potential PrEP needs (missing: 79), only 57.4% knew at least one of three key PrEP-related facts at the time of the survey. Our findings highlight substantial gaps in HIV testing and prevention among trans and non-binary individuals in Germany with potential needs for these services. Reducing barriers to testing and prevention is essential to enable broader access to these critical services.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10461-025-04631-z | DOI Listing |
Transfusion
March 2025
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background: Data from the National Blood Collection and Utilization Survey (NBCUS) suggest a stabilization in blood collections and transfusions following years of decline. Data from the 2023 NBCUS were analyzed to further understand national trends in US blood availability.
Study Design And Methods: In February 2024, all community-based (53) and hospital-based (104) blood collection centers, and a sample of transfusing hospitals were surveyed.
Front Cell Infect Microbiol
March 2025
Department of AIDS Research, Hebei Key Laboratory of Pathogen and Epidemiology of Infectious Disease, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Background: HIV-1 protease (PR)-reverse transcriptase (RT) inhibitors as national free antiretroviral drugs have been used for 20 years. Integrase strand transfer inhibitors (INSTIs) have been conditionally used as a component of HIV/AIDS treatment regimens in recent years. However, the systematic investigation on the changes in primary drug resistance (PDR) in Hebei province, China was limited.
View Article and Find Full Text PDFBMC Oral Health
March 2025
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Aim: Xerostomia is defined as a subjective complaint of dry mouth and is a prevalent condition. The study aims to estimate the cut point of the xerostomia inventory (XI) questionnaire for diagnosing dry mouth based on a saliva test.
Method: This prospective study was conducted in Dentistry School of Kerman University of Medical Sciences.
BMC Health Serv Res
March 2025
Asian Institute for Bioethics and Health Law, College of Medicine, Yonsei University, Seoul, Korea.
Introduction: The COVID-19 burden, coupled with unprecedented control measures including physical distancing, travel bans, and lockdowns in cities, has undoubtedly far-reaching consequences on healthcare services and has affected human immunodeficiency virus (HIV) and tuberculosis (TB) health services in both low- and high-income countries. This study, therefore, explored the perspective of HIV and TB health service providers to better understand how the pandemic impacted health service delivery in Ghana.
Method: This qualitative explorative study was conducted among HIV and TB healthcare providers (n = 30) in six districts of Ghana from March to May 2021 using in-depth interviews.
AIDS Behav
March 2025
Department of Family Science, School of Public Health, University of Maryland, College Park, Maryland, USA.
Synergistic interactions between substance use and violence (SAVA syndemic) are strongly associated with heightened risk for HIV acquisition in the African American population. While couple-based interventions have shown efficacy among at-risk and HIV-positive serodiscordant couples, no interventions have specifically targeted SAVA syndemic risk reduction for HIV-negative, high-risk, heterosexual African American couples in the United States. This pilot study tested the feasibility, safety, and preliminary effects of an integrated sexual risk reduction intervention for African American couples.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!